Cargando…
HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer
Human epidermal growth factor receptor 3 (HER3) is the only family member of the EGRF/HER family of receptor tyrosine kinases that lacks an active kinase domain (KD), which makes it an obligate binding partner with other receptors for its oncogenic role. When HER3 is activated in a ligand-dependent...
Autor principal: | Majumder, Avisek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648638/ https://www.ncbi.nlm.nih.gov/pubmed/37947595 http://dx.doi.org/10.3390/cells12212517 |
Ejemplares similares
-
Targeting Homocysteine and Hydrogen Sulfide Balance as Future Therapeutics in Cancer Treatment
por: Majumder, Avisek
Publicado: (2023) -
The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
por: Neth, Bryan J., et al.
Publicado: (2023) -
The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021) -
Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
por: Sarkar, Chandan, et al.
Publicado: (2020) -
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects
por: Pritam, Pingal, et al.
Publicado: (2022)